JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pérez-Filgueira, D. M.
Right arrow Articles by Escribano, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pérez-Filgueira, D. M.
Right arrow Articles by Escribano, J. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2006, p. 3114-3121, Vol. 44, No. 9
0095-1137/06/$08.00+0     doi:10.1128/JCM.00406-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Optimization and Validation of Recombinant Serological Tests for African Swine Fever Diagnosis Based on Detection of the p30 Protein Produced in Trichoplusia ni Larvae

D. M. Pérez-Filgueira,1,3,{dagger} F. González-Camacho,1,{dagger} C. Gallardo,2 P. Resino-Talaván,1 E. Blanco,2 E. Gómez-Casado,1 C. Alonso,1 and J. M. Escribano1*

Departamento de Biotecnología, INIA, Ctra A Coruña Km 7, 28040 Madrid, Spain,1 Centro de Investigación en Sanidad Animal, INIA, Valdeolmos 28130 Madrid, Spain,2 Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina3

Received 23 February 2006/ Returned for modification 23 April 2006/ Accepted 14 May 2006

We describe the validation of an enzyme-linked immunosorbent assay (ELISA) and confirmatory immunoblotting assays based on a recombinant p30 protein (p30r) produced in insect larvae using a baculovirus vector. Such validation included the following: (i) the scaling up and standardization of p30r production and the associated immunoassays, (ii) a broad immunological analysis using a large number of samples (a total of 672) from Spain and different African locations, and (iii) the detection of the ASF virus (ASFV)-antibody responses at different times after experimental infection. Yields of p30r reached up to 15% of the total protein recovered from the infected larvae at 3 days postinfection. Serological analysis of samples collected in Spain revealed that the p30r-based ELISA presented similar sensitivity to and higher specificity than the conventional Office International des Epizooties-approved ASFV ELISA. Moreover, the p30r ELISA was more sensitive than the conventional ELISA test in detecting ASFV-specific antibodies in experimentally infected animals at early times postinfection. Both the recombinant and conventional ELISAs presented variable rates of sensitivity and specificity with African samples, apparently related to their geographical origin. Comparative analyses performed on the sequences, predicted structures, and antigenicities of p30 proteins from different Spanish and African isolates suggested that variability among isolates might correlate with changes in antigenicity, thus affecting detection by the p30r ELISA. Our estimations indicate that more than 40,000 ELISA determinations and 2,000 confirmatory immunoblotting tests can be performed with the p30r protein obtained from a single infected larva, making this a feasible and inexpensive strategy for production of serological tests with application in developing countries.


* Corresponding author. Mailing address: Departamento de Biotecnología, INIA, Autovia A6, Km 7, 28040 Madrid, Spain. Phone: 34-913473917. Fax: 34-913573107. E-mail: escriban{at}inia.es.

{dagger} D. M. Pérez-Filgueira and F. González-Camacho contributed equally to the results presented in this paper.


Journal of Clinical Microbiology, September 2006, p. 3114-3121, Vol. 44, No. 9
0095-1137/06/$08.00+0     doi:10.1128/JCM.00406-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.